Association of macrophage migration inhibitory factor promoter polymorphism –173G/C with susceptibility to childhood asthma

Tarek Z. El-Adly; Sally Kamal; Hala Selim; Shahira Botros

doi:10.5114/ceji.2016.63126

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

3/2016
vol. 41

Send email

Copy url:

abstract:

Clinical immunology

Association of macrophage migration inhibitory factor promoter polymorphism –173G/C with susceptibility to childhood asthma

Tarek Z. El-Adly

,

Sally Kamal

,

Hala Selim

,

Shahira Botros

(Cent Eur J Immunol 2016; (3): 268-272)

DOI: https://doi.org/10.5114/ceji.2016.63126

Online publish date: 2016/10/25

View full text Get citation

PlumX metrics:

Introduction: Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that plays an important role in the pathogenesis of asthma. Polymorphisms associated with inflammatory diseases exist in the promoter region of MIF, which alter its expression. We aimed to study the association of MIF promoter polymorphism –173G/C with childhood asthma.

Material and methods: In this case-control study, we recruited 60 pediatric patients with bronchial asthma and 90 age- and sex-matched healthy controls. MIF-173G/C was genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

Results: Genotype distribution between cases and healthy controls was statistically evaluated. Our results revealed that the frequency of the MIF-173C allele was significantly higher in children with asthma than in the control group (p = 0.002, odds ratio [OR] = 3.61, 95% confidence interval [CI] = 1.63-7.97). The frequency of the MIF-173CC genotype was higher in the asthmatic children than in the controls (p = 0.028, OR = 6.24, 95% CI = 1.24-31.29). Comparing carriage of the MIF-173C allele in pediatric patients with asthma with that observed in healthy controls (GC + CC vs. GG) revealed a positive association with the disease (p = 0.019, OR = 3.12, 95% CI = 1.22-7.99).

Conclusions: These results suggest that MIF-173G/C polymorphism confers an increased risk of susceptibility to the development of childhood asthma in an Egyptian population.

keywords:

Association of macrophage migration inhibitory factor promoter polymorphism –173G/C with susceptibility to childhood asthma

Tarek Z. El-Adly , Sally Kamal , Hala Selim , Shahira Botros

children, polymorphism, asthma, promoter, macrophage migration inhibitory factor

Tarek Z. El-Adly

,

Sally Kamal

,

Hala Selim

,

Shahira Botros